Strio Ai, Inc

Nanobiosym is an innovative company based in Cambridge, MA that specializes in the integration of physics, biomedicine, and nanotechnology to create groundbreaking technologies. Their mission is to address global health, energy, and environmental challenges by incubating and commercializing transformational technologies with game-changing impact. Through their Nanobiosym Diagnostics division, they have developed the Gene-RADAR, a portable nanotechnology platform that enables rapid and accurate detection of genetic fingerprints from any biological organism, providing affordable and accessible diagnostic information. With a focus on maximizing global humanitarian impact, Nanobiosym has spearheaded the Nanobiosym Global Initiative, collaborating with governments, NGOs, academia, and industry leaders to bring emerging technologies to tackle pressing global challenges. Led by Dr. Anita Goel, a renowned figure in biophysics and nano-biotechnology, Nanobiosym is at the forefront of the nanotechnology revolution, aiming to redefine the rules of medical diagnosis and contribute to the advancement of modern medicine.Generated from the website

3rd Millennium, located in Waltham, Mass., is a leading provider of management consulting services and custom informatics system development for biopharmaceutical companies and other public and private life sciences institutions. Since 1994, the company has helped organizations manage, plan, specify, design, build and integrate informatics systems to support research and development programs. Its staff consists of Ph.D. level scientists with expertise in biology, biochemistry, bioinformatics and other related fields. The company is also comprised of computer scientists and software engineers with extensive knowledge and experience in building applications for the life sciences. 3rd Millennium s clients include Biogen, Cornell University, Ardais, Novartis, Phylos and Vertex.

Binx Health, Inc., based in Cambridge, MA, is a leader in rapid point-of-care testing for sexually transmitted infections, offering streamlined solutions that enable single-visit diagnosis and treatment for chlamydia and gonorrhea through their innovative binx io platform. Committed to enhancing access to sexual health testing, the company actively collaborates with healthcare organizations and institutions to improve patient care and outcomes. With a robust presence across the United States, binx health focuses on expanding its reach and capabilities through strategic partnerships and initiatives aimed at increasing awareness and accessibility of essential healthcare services. Their ongoing efforts reflect a dedication to addressing public health challenges while promoting antibiotic stewardship and equitable healthcare solutions. Generated from the website